BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 11026878)

  • 1. Trichomonas vaginalis epidemiology: parameterising and analysing a model of treatment interventions.
    Bowden FJ; Garnett GP
    Sex Transm Infect; 2000 Aug; 76(4):248-56. PubMed ID: 11026878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High prevalence of trichomoniasis in rural men in Mwanza, Tanzania: results from a population based study.
    Watson-Jones D; Mugeye K; Mayaud P; Ndeki L; Todd J; Mosha F; West B; Cleophas-Frisch B; Grosskurth H; Laga M; Hayes R; Mabey D; Buvé A
    Sex Transm Infect; 2000 Oct; 76(5):355-62. PubMed ID: 11141851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trichomonas vaginalis infection in Nigerian pregnant women and risk factors associated with sexually transmitted infections.
    Oyeyemi OT; Fadipe O; Oyeyemi IT
    Int J STD AIDS; 2016 Nov; 27(13):1187-1193. PubMed ID: 26438604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trichomonas vaginalis infection in male sexual partners: implications for diagnosis, treatment, and prevention.
    Seña AC; Miller WC; Hobbs MM; Schwebke JR; Leone PA; Swygard H; Atashili J; Cohen MS
    Clin Infect Dis; 2007 Jan; 44(1):13-22. PubMed ID: 17143809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Trichomonas vaginalis with sociodemographic factors and other STDs among female inmates in Lisbon.
    Garcia A; Exposto F; Prieto E; Lopes M; Duarte A; Correia da Silva R
    Int J STD AIDS; 2004 Sep; 15(9):615-8. PubMed ID: 15339370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High rates of Trichomonas vaginalis among men attending a sexually transmitted diseases clinic: implications for screening and urethritis management.
    Schwebke JR; Hook EW
    J Infect Dis; 2003 Aug; 188(3):465-8. PubMed ID: 12870131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trichomonas vaginalis infection: the most prevalent nonviral sexually transmitted infection receives the least public health attention.
    Van der Pol B
    Clin Infect Dis; 2007 Jan; 44(1):23-5. PubMed ID: 17143810
    [No Abstract]   [Full Text] [Related]  

  • 8. [Advances in the study of trichomoniasis in men].
    Sang H; Zhou WQ; Ni RZ; Gao JP
    Zhonghua Nan Ke Xue; 2002; 8(1):61-3. PubMed ID: 12479053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlates of Trichomonas vaginalis Among Middle Age and Older Adults Who Use Drugs.
    Hearn LE; Whitehead NE; Dunne EM; Latimer WW
    Subst Use Misuse; 2015; 50(12):1501-9. PubMed ID: 26583203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening for sexually transmitted diseases in human immunodeficiency virus-positive patients in Peru reveals an absence of Chlamydia trachomatis and identifies Trichomonas vaginalis in pharyngeal specimens.
    Press N; Chavez VM; Ticona E; Calderon M; Apolinario IS; Culotta A; Arevalo J; Gilman RH;
    Clin Infect Dis; 2001 Mar; 32(5):808-14. PubMed ID: 11229850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural history of urogenital trichomoniasis in men.
    Krieger JN; Verdon M; Siegel N; Holmes KK
    J Urol; 1993 Jun; 149(6):1455-8. PubMed ID: 8501787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Global epidemiology and control of Trichomonas vaginalis.
    Johnston VJ; Mabey DC
    Curr Opin Infect Dis; 2008 Feb; 21(1):56-64. PubMed ID: 18192787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical laboratory assessments for Mycoplasma genitalium in a high-prevalence sexually-transmitted infection community reveal epidemiologic dichotomies with Trichomonas vaginalis.
    Munson E; Munson KL; Schell RF
    Expert Rev Anti Infect Ther; 2017 Feb; 15(2):133-145. PubMed ID: 27894204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Global epidemiology of Trichomonas vaginalis.
    Poole DN; McClelland RS
    Sex Transm Infect; 2013 Sep; 89(6):418-22. PubMed ID: 23744960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Review of Evidence-Based Care of Symptomatic Trichomoniasis and Asymptomatic Trichomonas vaginalis Infections.
    Meites E; Gaydos CA; Hobbs MM; Kissinger P; Nyirjesy P; Schwebke JR; Secor WE; Sobel JD; Workowski KA
    Clin Infect Dis; 2015 Dec; 61 Suppl 8(Suppl 8):S837-48. PubMed ID: 26602621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of Trichomonas vaginalis Infection Among US Males, 2013-2016.
    Daugherty M; Glynn K; Byler T
    Clin Infect Dis; 2019 Jan; 68(3):460-465. PubMed ID: 29893808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening for Trichomonas vaginalis in a Large High-Risk Population: Prevalence Among Men and Women Determined by Nucleic Acid Amplification Testing.
    Schwebke J; Merriweather A; Massingale S; Scisney M; Hill C; Getman D
    Sex Transm Dis; 2018 May; 45(5):e23-e24. PubMed ID: 29465684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trichomonas vaginalis infection among women receiving gynaecological care at an Alabama HIV Clinic.
    Muzny CA; Rivers CA; Austin EL; Schwebke JR
    Sex Transm Infect; 2013 Sep; 89(6):514-8. PubMed ID: 23449600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalent, treatable and significant: barriers to the control of Trichomonas vaginalis in women.
    Hillier SL
    Sex Transm Infect; 2013 Sep; 89(6):415. PubMed ID: 23956294
    [No Abstract]   [Full Text] [Related]  

  • 20. Trichomoniasis: under control or undercontrolled?
    Soper D
    Am J Obstet Gynecol; 2004 Jan; 190(1):281-90. PubMed ID: 14749674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.